Immortalized Human Pancreatic Neuroendocrine Tumor Cells |
|||
| CSC-I2050Z | Creative Bioarray | One Frozen vial | Ask for price |
Iga Antibody Laboratories manufactures the gliadin antibody iga neuroendocrine tumor reagents distributed by Genprice. The Gliadin Antibody Iga Neuroendocrine Tumor reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact iga antibody. Other Gliadin products are available in stock. Specificity: Gliadin Category: Antibody Group: Iga Neuroendocrine
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF680 conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF680 conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF680R conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF680R conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405M conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405M conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF543 conjugate, Concentration: 0.1mg/mL |
||
Iga Neuroendocrine information
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNUB2552-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL |
|||
Multiple organs neuroendocrine tumor tissue array with normal tissue |
|||
| NE841 | TissueArray | each | EUR 354 |
|
Description: Multiple organs neuroendocrine tumor tissue array with normal tissue |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC802561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC802561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF680 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC812561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC812561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF680R conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC432561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF543 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC432561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF543 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC052561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC052561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF405M conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC552561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF555 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC552561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF555 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC702561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC702561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF770 conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC612561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF660R conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNC612561-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF660R conjugate, Concentration: 0.1mg/mL |
|||
NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561) Antibody |
|||
| BNCH2561-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||